About Us
ROSE Diagnostics was created in California in 2023 with a visionary idea at its core - to address an unmet need in healthcare by bridging the gap between pathology labs and cancer biopsy clinics. Recognizing the potential to significantly improve patient outcomes, we conceptualized a unique approach to diagnostic testing.
At the heart of our journey is a team of founders who are leaders in the diagnostics industry, boasting a collaborative history marked by many successful product launches. ROSE Diagnostics is comprised of like-minded scientists, product developers, clinical partners, business leaders, and regulatory experts.
Our team brings 20+ years of experience and knowledge to the table, embodying a collective expertise geared towards making a meaningful impact on diagnostic practices.
Management Team
Andrew Morris
CEO, Founder
The Experienced Entrepreneur - Andrew brings an abundance of experience as a company co-founder, CEO, and CFO. Contributions have been in leadership, operations, finance, corporate development, and fund raising. 20+ years experience in diagnostics and life sciences companies; 10 years active Air Force service as a biosciences officer. (HSBc, MSc, MBA)
Eric Brouwer, PhD
CSO, Founder
The i-STAT Point-of-Care Science Guy - Eric is passionate about developing innovative diagnostic products that transform healthcare delivery. He has 16+ years of experience in biosensors, microfluidics, and successful US/Canada and EU regulatory applications. As R&D lead, he launched i-STAT’s CHEM8+, where he led the technological side of its cartridge product portfolio (blood, gas, electrolyte, and chemistry assays), accounting for 80% of cartridge sales - i-STAT was bought by Abbott for $392M.
Adolfo Velazquez
CTO, Founder
The technical wizard behind our 5 minute-test - Adolfo has deep experience in developing market-leading point-of-care sensors. He has led the development of multiple impactful & approved rapid point-of-care tests, from concept to commercialization. At Quidel Corp., he led the development of impactful SOFIA point-of-care products: Influenza A+B; RSV FIA; Strep A; Quantitative Vitamin D; and C. difficile.
Donna Padavan, PhD
VP Clinical & Regulatory Affairs, Founder
The Clinical Trials and Regulatory Navigator - Donna is a seasoned professional with over two decades of experience in the medical device industry, specializing in clinical trials, regulatory processes, and medical innovation. She has a proven record of managing FDA pre-submissions, securing Health Canada approvals, and handling intellectual property rights. Her expertise is marked by commitment to delivering results and advancing scientific knowledge.